Test your basic knowledge |

USMLE/COMLEX Step 1 Pharmacology One Liners

Instructions:
  • Answer 50 questions in 15 minutes.
  • If you are not ready to take this test, you can study here.
  • Match each statement with the correct term.
  • Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.

This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.
1. Most important potential SE of metformin






2. 5HT-3 antagonist used in chemotherapeutic induced emesis






3. Used for prevention of postmenopausal osteoporosis in women






4. This agent regenerates active cholinesterase and is a chemical antagonist used to treat organophosphate exposure






5. Toxic to the liver - kidney - lungs - bone marrow - peripheral nerves - and cause brain damage in animals - sudden death has occurred following inhalation






6. SE of tPA






7. IV barbiturate used as a pre - op anesthetic






8. TCA used in chronic pain - enuresis - and ADD






9. NSAID also available as an ophthalmic preparation






10. Lethal arrhythmias resulting from concurrent therapy with azole fungals (metabolized by CYP 3A4) and these antihistamines which inhibit the 3A4 iso - enzyme.






11. Alpha - glucosidase inhibitor associated with elevation of LFT's






12. Antipsychotics that reduce positive symptoms only






13. MOA of colchicine (used in acute gout)






14. Tolerance is marked and abstinence syndrome occurs






15. Anti - Parkinson's drug which increases intraocular pressure and is contraindicated in closed angle glaucoma






16. Antidote used for benzodiazepine toxicity






17. DOC for management of acute ventricular arrhythmias






18. Antidote to reverse actions of warfarin






19. Carbonic anhydrase inhibitor






20. Agent to treat torsades de pointes






21. Anti - seizure agent that exhibits non - linear metabolism - highly protein bound - causes fetal hydantoin syndrome - and stimulates hepatic metabolism






22. Three C's associated with TCA toxicity






23. Antiarrhythmic that exhibits Class II and III properties






24. Mast cells to reduce release of hisamine and inflammatory mediators






25. Block cardiac adverse effects of thyrotoxicosis such as tachycardia - inhibits the conversion of T4 to T3






26. Agent used for neurological deficits in megaloblastic anemia






27. Beta - blockers should be used cautiously in






28. MOA of repaglinide






29. Drug ofter used in combination with TNF - alpha inhitors for RA






30. Mineralocorticoids






31. MOA of class I A (eg. Procainamide) - class IB (eg. Lidocaine) - and class IC (eg. Flecainide) antiarrhythmics






32. Only direct acting agent that is very lipid soluble and used in glaucoma






33. Interact with microtubules (but unlike vinca which prevent disassembly of tubules) - it stabilizes tubulin and cells remain frozen in metaphase






34. Commonly abused LA which has cardiovascular toxicity including severe hypertension with cerebral hemorrhage - cardiac arrhythmias - and myocardial infarction






35. Drug of choice for myoclonic seizures






36. Pneumonic for beta receptors






37. MAOI should not be administered with SSRI's or potent TCA's due to development of this condition






38. Relates the amount of drug in the body to the plasma concentration






39. Most inhaled anesthetics SE






40. This beta blocker is highly lipid soluble and may account for side effects such as nightmares






41. Presynaptic Alpha 2 agonist used in HTN - and acts centrally






42. Rapid acting - crystalline zinc insulin used to reverse acute hyperglycemia






43. Benzodiazepine that undergo extrahepatic conjugation (which are useful in older or hepatically impaired)






44. Intermediate acting glucocorticoids






45. Penicillins active against penicillinase secreting bacteria






46. Antiglaucoma organophosphate






47. Activation of these receptors close Ca2+ ion channels to inhibit neurotransmitter release






48. Agent used in acutely decompensated CHF resembling natriuretic peptide






49. LA causing methemoglobinemia






50. SE of methyldopa

Warning: Invalid argument supplied for foreach() in /var/www/html/basicversity.com/show_quiz.php on line 183